Description
PRINCIPIO ACTIVO: ORLISTART Y L CARNITINA
DOSIS: 375 G
FORMA FARMACÉUTICA: 1 SOLUCION JERINGA RELLENADA
XYNTHASOL INY 500 UI FA | Frasco Ámpula | Factor de Actividad | 1 UN | CSL Behring
PRINCIPIO ACTIVO: METRONIDAZOL-NISTATINA
AMOEBRIZ 300/150MG 2 TAB SOLAN PHAR PRINCIPIO ACTIVO: ORLISTART Y LPRINCIPIO ACTIVO: MEBENDAZOL QUINFAMIDA DOSIS: 300 MG FORMA FARMACUTICA: 2 TABLETAS PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
